$BKKT

Henderson Joseph Sean-Walsh sold $783 of BKKT

Henderson Joseph Sean-Walsh (Chief Accounting Officer) sold 94 shares of Bakkt, Inc. (BKKT) at $8.33 on 2026-07-15.

Original reporting
SEC EDGAR · Henderson Joseph Sean-Walsh
Published Jul 17, 2026, 5:21 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 17, 2026, 5:23 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$BKKT
Neutral
medium confidence
Mentioned
$BKKT
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$BKKTNeutralLow
01

Why it matters

The filing provides verified transaction details but does not include any new operational, financial, or regulatory development for BKKT.

02

Market read

Traders may note the insider sale, but the modest value and lack of additional catalysts make it low-signal.

03

What to watch

Insider sales can be driven by personal liquidity needs, taxes, or diversification rather than company outlook; no other BKKT-specific news is provided.

Relevance 3/10Novelty 3/10Timing: new SEC Form 4 filed 2026-07-17, covering a 2026-07-15 sale

Background

The article is an SEC Form 4 insider transaction disclosure for Bakkt, Inc.

Company-level read

Ticker impact

$BKKTNeutralMedium confidence
Context

Bakkt insider Henderson Joseph Sean-Walsh sold 94 shares on 2026-07-15 at $8.3300, per a new SEC Form 4 filing.

Expected impact

Likely minimal near-term impact; any effect is more informational than fundamental.

Evidence & confidence

Form 4 confirms the transaction details, but the size ($783) and lack of additional company-specific catalysts limit tradable signal.

Market effects

No clear read-across to the broader crypto/fintech sector from a single small insider sale.

None indicated.

None indicated.

Counterpoint

Absence of a 10b5-1 plan could be interpreted as less mechanical selling, but the transaction size is too small to matter.

Key entities

  • Bakkt, Inc.

    Subject of the Form 4 insider sale disclosure.

  • Henderson Joseph Sean-Walsh

    Chief Accounting Officer who sold 94 shares.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$BKKTMedAI 8/10

Bakkt (BKKT) Q2 2026 Earnings Call Transcript

Bakkt (BKKT) reported Q2 2026 revenue of $170.1 million, down 70% from $568.1 million, citing client transitions and weaker digital asset trading volumes. GAAP net income was $80.8 million, driven mainly by a $98.5 million non-cash gain from Transchem warrants. Total transacting volume was $168.8 million; management reiterated an EBITDA breakeven target in Q4 2026.

$BKKTMed

Bakkt Inc (BKKT) (Q2 2026) Earnings Call Highlights: Strong GAAP Net Income

Bakkt’s CEO Akshay Naheta said the company expects adjusted EBITDA break-even in Q4 2026, without a specific date, citing execution and client activations. Management discussed take rates, cross-border margins, and reaffirmed a 2026 TTV target of about $2.5 billion. The firm outlined post-DTR acquisition progress and Bakkt Agent MAU target of ~25,000 by year-end 2026.

$BKKTMed

Bakkt, Inc. (BKKT): Results of Operations and Financial Condition

Bakkt, Inc. (BKKT) filed an SEC Form 8-K — Results of Operations and Financial Condition. Bakkt Reports Second Quarter 2026 Results - GAAP net income of $80.8 million, or $1.96 per basic and $1.94 per diluted share - Six commercial offerings live across Bakkt Markets; Total Transacting Volume (“TTV”) of $168.8 million in Q2, including payments volume generated on acqu